EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 86 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,797,788 | +29.1% | 600,474 | +40.6% | 0.00% | 0.0% |
| Q2 2023 | $3,715,344 | +79.9% | 427,051 | -39.2% | 0.00% | – |
| Q1 2023 | $2,065,591 | -22.6% | 702,582 | -7.9% | 0.00% | -100.0% |
| Q4 2022 | $2,669,762 | -60.4% | 762,789 | -10.5% | 0.00% | -50.0% |
| Q3 2022 | $6,745,000 | -3.4% | 852,705 | -3.9% | 0.00% | 0.0% |
| Q2 2022 | $6,985,000 | -34.0% | 887,632 | +1.9% | 0.00% | 0.0% |
| Q1 2022 | $10,584,000 | +39.0% | 871,101 | +40.0% | 0.00% | 0.0% |
| Q4 2021 | $7,614,000 | +1770.8% | 622,018 | +1491.1% | 0.00% | – |
| Q3 2021 | $407,000 | -81.4% | 39,093 | -83.9% | 0.00% | – |
| Q2 2021 | $2,186,000 | +56.1% | 243,138 | +76.4% | 0.00% | – |
| Q1 2021 | $1,400,000 | – | 137,837 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,490,921 | $27,892,459 | 24.59% |
| ACUTA CAPITAL PARTNERS, LLC | 300,128 | $2,398,023 | 1.61% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,492,147 | $27,902,255 | 1.51% |
| Cormorant Asset Management, LP | 3,200,000 | $25,568,000 | 1.49% |
| Samsara BioCapital, LLC | 432,000 | $3,451,680 | 1.06% |
| Ghost Tree Capital, LLC | 325,000 | $2,596,750 | 0.85% |
| RA Capital Management | 3,370,506 | $26,930,343 | 0.53% |
| Ikarian Capital, LLC | 4,487 | $3,585,113 | 0.43% |
| Affinity Asset Advisors, LLC | 155,000 | $1,238,450 | 0.35% |
| SECTORAL ASSET MANAGEMENT INC | 176,080 | $1,406,879 | 0.27% |